Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Mind over matter: could a smartphone app supercharge spine surgery recovery?

NCT ID NCT07766824

Symptom relief Sponsor: National University of Natural Medicine Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 17, 2026 · Last updated Aug 18, 2026 · Updated 1 time

Summary

This trial tests an online platform called Ready Set Recover, designed to help people prepare for and recover from spine surgery. The platform offers education, mindfulness, gratitude exercises, and gentle movement to support mental well-being and patient engagement. Researchers are enrolling adults undergoing medium-to-long spinal fusion to see if the tool is feasible, acceptable, and helpful in improving recovery experiences.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Ready Set Recover, an online mobile health platform providing education, mindfulness, gratitude practices, and guided movement to support surgical preparation and recovery.
What this could lead to
If effective, this digital tool could become a low-cost, scalable way to improve recovery and reduce pain after spine surgery, potentially extending to other surgical fields.
What could go wrong
This is a small early-phase pilot focused on feasibility, not proof of effectiveness. Results may not generalize, and the platform's impact on clinical outcomes remains uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Early phase 1

The earliest testing in people: a first look at safety, in a very small group.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Sep 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients deemed candidates for medium-/long-segment spinal fusion * Patients who score a \> 4 on a 0-10 NRS for the question "How motivated are you to participate in this research study?" * At least 18 years of age and not older than 80 at the time of study enrollment •Ability to read and understand English * Daily access to the internet via cell phone, tablet, or computer Exclusion Criteria: * Have received epidural steroid injection for low back pain, lumbosacral radiculopathy, or scoliosis in the prior 3 months * Have received a surgical intervention for low back pain, lumbosacral radiculopathy, or scoliosis in the previous 6 months * Concurrent diagnosis of cancer * Cognitive impairment * Severe comorbidities (e.g., terminal illness, severe organ failure) * Non-elective/emergency surgery in the past

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cervical myelopathy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

scoliosis spondylolisthesis spondylosis spondylosis, cervical

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cervical myelopathy Cervical spondylosis and spondylolisthesis Chronic low back pain Lumbar spondylolisthesis Lumbar spondylosis Medium-/long-segment spinal fusion patients Post laminectomy cervical syndrome Scoliosis patients Spine surgeons

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Oregon Health & Science University

    Portland, Oregon, 97201, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.